Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis.
Wang L, Zhu L, Liang C, Huang X, Liu Z, Huo J, Zhang Y, Zhang Y, Chen L, Xu H, Li X, Xu L, Kuang M, Wong CC, Yu J.
Wang L, et al. Among authors: xu l, xu h.
J Hepatol. 2023 Nov;79(5):1185-1200. doi: 10.1016/j.jhep.2023.06.021. Epub 2023 Jul 17.
J Hepatol. 2023.
PMID: 37459919
Free article.